• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和青少年成熟 B 细胞非霍奇金淋巴瘤细胞遗传学异常的预后影响:日本儿科白血病/淋巴瘤研究组(JPLSG)的报告。

Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).

机构信息

Japanese Pediatric Leukemia/Lymphoma Study Group, Lymphoma Committee, Japan.

出版信息

Pediatr Blood Cancer. 2015 Jul;62(7):1294-6. doi: 10.1002/pbc.25482. Epub 2015 Mar 19.

DOI:10.1002/pbc.25482
PMID:25790170
Abstract

Little information is available on cytogenetic abnormalities and their prognostic importance in childhood mature B-cell non-Hodgkin lymphoma (B-NHL). We performed a review of 79 abnormal karyotypes in childhood B-NHL treated by a uniform protocol. Del(17p) was independently associated with significantly inferior event-free survival in Burkitt or Burkitt-like lymphoma. The adverse prognosis of MYC/8q24 rearrangement, +7q or del(13q), was not observed, which had been suggested as risk factors in FAB/LMB96. Our results imply the possible existence of a biological difference among ethnicities and should be useful to narrow down the gene causing poor prognosis in childhood B-NHL.

摘要

关于儿童成熟 B 细胞非霍奇金淋巴瘤(B-NHL)中的细胞遗传学异常及其预后意义,目前信息有限。我们通过统一的方案,对 79 例儿童 B-NHL 的异常核型进行了回顾性分析。del(17p)与伯基特或伯基特样淋巴瘤的无事件生存显著相关。而在 FAB/LMB96 中被认为是危险因素的 MYC/8q24 重排、+7q 或 del(13q),其不良预后并未被观察到。我们的研究结果表明,在不同种族之间可能存在生物学差异,这对于缩小导致儿童 B-NHL 预后不良的基因范围可能是有用的。

相似文献

1
Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).儿童和青少年成熟 B 细胞非霍奇金淋巴瘤细胞遗传学异常的预后影响:日本儿科白血病/淋巴瘤研究组(JPLSG)的报告。
Pediatr Blood Cancer. 2015 Jul;62(7):1294-6. doi: 10.1002/pbc.25482. Epub 2015 Mar 19.
2
Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.特定的细胞遗传学异常与儿童和青少年成熟B细胞非霍奇金淋巴瘤的预后显著较差相关:FAB/LMB 96国际研究结果
Leukemia. 2009 Feb;23(2):323-31. doi: 10.1038/leu.2008.312. Epub 2008 Nov 20.
3
Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.儿童和青少年成熟B细胞淋巴瘤及白血病——标准化疗方案综述与展望
Pediatr Hematol Oncol. 2013 Sep;30(6):465-83. doi: 10.3109/08880018.2013.783891. Epub 2013 Apr 9.
4
Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.奥地利儿童及青少年恶性非霍奇金淋巴瘤——1986年至2000年的治疗结果
Wien Klin Wochenschr. 2002 Dec 30;114(23-24):978-86.
5
Improved treatment results of children with B-cell non-Hodgkin lymphoma: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study.儿童 B 细胞非霍奇金淋巴瘤治疗效果的改善:来自日本儿科白血病/淋巴瘤研究组 B-NHL03 研究的报告。
Pediatr Blood Cancer. 2014 Jul;61(7):1215-21. doi: 10.1002/pbc.24975. Epub 2014 Feb 13.
6
Pediatric B-Cell Lymphoma With Lymphoblastic Morphology, TdT Expression, MYC Rearrangement, and Features Overlapping With Burkitt Lymphoma.具有原始淋巴细胞形态、末端脱氧核苷酸转移酶(TdT)表达、MYC重排且具有与伯基特淋巴瘤重叠特征的儿童B细胞淋巴瘤
Pediatr Blood Cancer. 2016 May;63(5):938-40. doi: 10.1002/pbc.25907. Epub 2016 Jan 19.
7
Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.基因组畸变模式表明,具有复杂核型的伯基特淋巴瘤与具有 MYC 重排的其他侵袭性 B 细胞淋巴瘤不同。
Genes Chromosomes Cancer. 2013 Jan;52(1):81-92. doi: 10.1002/gcc.22008. Epub 2012 Sep 25.
8
Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92).意大利儿科学血液学与肿瘤学协会首个治疗儿童B细胞非霍奇金淋巴瘤方案(AIEOP LNH92)的长期结果
Cancer. 2004 Jul 15;101(2):385-94. doi: 10.1002/cncr.20382.
9
MYC/BCL2 double-hit high-grade B-cell lymphoma.MYC/BCL2 双打击高级别 B 细胞淋巴瘤。
Adv Anat Pathol. 2013 Sep;20(5):315-26. doi: 10.1097/PAP.0b013e3182a289f2.
10
Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.根据非霍奇金淋巴瘤柏林-法兰克福-明斯特方案治疗的儿童侵袭性B细胞淋巴瘤中ID3-TCF3-CCND3通路突变的相关性
Haematologica. 2017 Jun;102(6):1091-1098. doi: 10.3324/haematol.2016.156885. Epub 2017 Feb 16.

引用本文的文献

1
Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy.ARID1A和TP53突变对接受CAR-T细胞疗法治疗的小儿难治性或复发性成熟B细胞淋巴瘤的影响。
Cancer Cell Int. 2023 Nov 19;23(1):281. doi: 10.1186/s12935-023-03122-2.
2
Increased expression of microRNA-503 and reduced expression of kangai-1 in B-cell non-Hodgkin's lymphoma.B细胞非霍奇金淋巴瘤中微小RNA-503表达增加及抗癌-1表达降低。
Exp Ther Med. 2016 Mar;11(3):917-922. doi: 10.3892/etm.2016.2971. Epub 2016 Jan 8.